Associados

Início / Associados / Página 10

Categoria:

Janeiro 22, 2024

Associados | Takeda

U.S. FDA Approves Takeda’s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

– HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase], the Only up to Once...

Janeiro 12, 2024

Associados | EntoGreen

Ministra da Ciência e da Ensino Superior, Doutora Elvira Fortunato, visita as Unidades de I&D e Industrial da EntoGreen durante a sua visita a Santarém

• Escola Superior Agrária de Santarém e EntoGreen fazem parte do roteiro de visita da...

Janeiro 11, 2024

Associados | CellmAbs

CellmAbs Announces Patent Assignment and Licensing Agreement with BioNTech

CellmAbs S.A. (“CellmAbs”), a Portuguese biotech company founded in 2019 and focused on the research...

Janeiro 8, 2024

Associados | Pfizer

PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer

– PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial – – Confirmatory trial found...

Novembro 30, 2023

Associados | MicroHarvest

MicroHarvest launches pilot plant in Lisbon to produce single-cell protein ingredients

• Pilot plant marks critical milestone towards commercialization, allowing prototype production and...

Novembro 23, 2023

Alnylam | Associados

Alnylam Presents Positive Results from the KARDIA-1 Phase 2 Dose-Ranging Study of Zilebesiran, an Investigational RNAi Therapeutic in Development for the Treatment of Hypertension in Patients at High Cardiovascular Risk

– Zilebesiran Met Primary Endpoint Demonstrating Up to 16.7 mmHg Placebo-Adjusted Reduction of 24-Hour Mean...